By James Illman2016-10-24T00:01:00
Patient access to some innovative drugs and other interventions could be brought forward by up to four years by restructuring the NHS’s approval and adoption process, a government commissioned review has concluded.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud